[HTML][HTML] Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya… - … Surgery and Nutrition, 2024 - ncbi.nlm.nih.gov
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya… - Hepatobiliary …, 2024 - pubmed.ncbi.nlm.nih.gov
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
[HTML][HTML] Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya… - Hepatobiliary …, 2024 - hbsn.amegroups.org
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
[PDF][PDF] Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya, E Assenat… - Prevention, 2023 - cdn.amegroups.cn
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, J Bedoya, E Assenat… - … Surgery and Nutrition, 2023 - europepmc.org
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
[PDF][PDF] Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya, E Assenat… - Prevention, 2024 - cdn.amegroups.cn
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives.
A Herrero, C Toubert, JU Bedoya… - … Surgery and Nutrition, 2023 - europepmc.org
Despite the improvements in surgical and medical therapy for hepatocellular carcinoma
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
(HCC), recurrence still represents a major issue. Up to 70% of patients can experience HCC …
[引用][C] Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives
A Herrero, C Toubert, JU Bedoya… - Hepatobiliary …, 2023 - hbsn.amegroups.org
Management of hepatocellular carcinoma recurrence after liver surgery and thermal
ablations: state of the art and future perspectives - Herrero - Hepatobiliary Surgery and …
ablations: state of the art and future perspectives - Herrero - Hepatobiliary Surgery and …